Histone deacetylase inhibitor panobinostat in combination with rapamycin confers enhanced efficacy against triple-negative breast cancer

Kunlin Wu(Hainan University), Xiangjin Chen(First Affiliated Hospital of Fujian Medical University), Sunwang Xu(Fujian Medical University), Lingjun Kong(Qinghai University), Ling Chen(Fujian Medical University), Junyu Lin(Fujian Medical University), Linlin Zhou(Beijing University of Chemical Technology), Huihao Zhang(Fujian Medical University), Caiqin Mo(Fujian Medical University)
Experimental Cell Research
September 21, 2022
Cited by 9


Related Papers